Premium
Clinical and noninvasive instrumental evaluation of the efficacy of a nonsteroidal anti‐inflammatory 8‐beta glycyrrhetinic acid cream for the treatment of erythema in rosacea
Author(s) -
Cameli Norma,
Mariano Maria,
Zanniello Ramona,
Berardesca Enzo
Publication year - 2020
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.14224
Subject(s) - medicine , rosacea , nonsteroidal , erythema , dermatology , pharmacology , acne
Rosacea is a very common chronic facial dermatosis characterized by a multiphase evolution. Inflammation is an important reaction in rosacea not only due to inflammatory reactions to cutaneous microorganisms, such as Demodex follicolorum , but also to ultraviolet damage that generates reactive oxygen species. This study evaluated the efficacy and tolerability of a nonsteroidal anti‐inflammatory 18‐beta glycyrrhetinic acid cream for the treatment of mild rosacea by means of noninvasive methods. A total of 24 subjects suffering from erythemato‐telangiectatic or mild papulo‐pustular rosacea were recruited in the trial. Twelve patients applied an anti‐inflammatory cream with 18‐beta glycyrrhetinic acid twice daily for 20 days and 12 patients, recruited as control, applied the same formulation without 18‐beta glycyrrhetinic acid. After 10 days of treatment, a significant reduction of erythema was recorded in the patient sample who applied the 18‐beta glycyrrhetinic acid cream, the mean change from baseline showed an increase in hydration level of the skin surface but it was not statistically significant. The use of 18‐beta glycyrrhetinic acid cream can be helpful in managing symptoms and condition of rosacea skin, especially in the management of erythema.